DavidBruceKudrowMD
Neurology • Century City, CAHeadache
Director, California Medical Clinic for Headache. Director, Headache Clinic Harbor-UCLA Medical Center. Assistant Clinical Professor in Neurology UCLA David Geffen School of Medicine.
Dr. Kudrow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2080 Century Park East
Suite 805
Century City, CA 90067Phone+1 310-315-1456Fax+1 310-315-1486
Summary
- Dr. David Kudrow is a neurologist in Century City, CA and is affiliated with Providence Saint John's Health Center. He received his medical degree from University of Southern California School of Medicine and has been in practice 35 years. He specializes in headache and is experienced in migraine disorders and headache disorders.
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterResidency, Neurology, 1987 - 1991
UCLA-VA Greater Los AngelesInternship, Internal Medicine, 1986 - 1987
Keck School of Medicine of the University of Southern CaliforniaClass of 1986
Certifications & Licensure
IL State Medical License 2019 - 2026
MT State Medical License 2020 - 2026
NY State Medical License 2018 - 2026
TX State Medical License 2020 - 2026
UT State Medical License 2019 - 2026
AZ State Medical License 2021 - 2025
CA State Medical License 1988 - 2025- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine. Start of enrollment: 2005 Dec 01
- Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine Start of enrollment: 2008 Apr 01
- Preventive Treatment of Episodic and Chronic Migraine Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 62 citationsEarly onset of efficacy with erenumab in patients with episodic and chronic migraineTodd J. Schwedt, Uwe Reuter, Stewart J. Tepper, Messoud Ashina, David Kudrow
The Journal of Headache and Pain. 2018-10-01 - 364 citationsARISE: A Phase 3 randomized trial of erenumab for episodic migraine:David W. Dodick, Messoud Ashina, Jan Lewis Brandes, David Kudrow, Michel Lanteri-Minet
Cephalalgia. 2018-02-22 - 164 citationsNon-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.Stephen D. Silberstein, Laszlo L. Mechtler, David Kudrow, Anne H. Calhoun, Candace McClure
Headache. 2016-09-01
Press Mentions
- Long-Term Safety and Tolerability of Eptinezumab in Patients with Chronic Migraine: A 2-Year, Open-Label, Phase 3 TrialMarch 19th, 2021
FDA Approves Galcanezumab-Gnlm for Episodic Cluster HeadacheJune 5th, 2019
Alder BioPharmaceuticals® to Present New Analyses of Eptinezumab’s Clinical Trial Data Describing Early, Robust Migraine Prevention and Quality of Life Impact at 2019 American Academy of Neurology Annual MeetingApril 23rd, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
